Accelerating Radiopharmaceutical Innovation
BAMF Health is transforming personalized medicine through radiopharmaceuticals, enabling earlier detection, more accurate diagnosis, and targeted treatment for diseases like cancer, Alzheimer’s, and beyond.
To bring this vision to life, we created BAMF RadioNexus: the first-of-its-kind clinical trials network dedicated exclusively to radiopharmaceutical research.
What is BAMF RadioNexus?
BAMF RadioNexus is a specialized clinical trials platform dedicated to radiopharmaceutical innovation. We partner with pharmaceutical sponsors and health systems to overcome the operational, regulatory, and logistical complexities that often slow these critical studies down.
Whether you’re advancing targeted radiopharmaceuticals or expanding your site’s capacity for theranostic research, RadioNexus helps you build infrastructure, grow expertise, and access the support needed to initiate and complete complex trials—faster, and with confidence.
Why Partner with BAMF RadioNexus?
For Pharmaceutical Sponsors
- Faster, more reliable study startup and execution
- Access to diverse patient populations
- Consistent trial workflows and high-quality data capture
- Experienced, high-performing partners
For Clinical Sites and Health Systems
- Tailored onboarding and training
- Best practices in regulatory navigation and operational readiness
- Priority access to cutting-edge trials
- Grow research capabilities and patient care offerings
Our Process
We analyze your site’s current clinical research capabilities and develop a customized roadmap for launching and scaling clinical trials across single or multi-location systems.
We equip your site with operational infrastructure, including scheduling workflows, imaging and data capture processes, radiation safety tools, budgeting templates, team training, and more.
We assist with site qualification and feasibility, regulatory submissions and IRB support, development of protocol-specific workflows, and site onboarding.
We identify and act on opportunities to improve enrollment, reduce protocol deviations, increase cross-site coordination, and drive operational efficiencies.
Ready to Shape the Future of Personalized Care?
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Clinical Trial General Interest Copy link
If you are interested in learning more about participating in a clinical trial, please fill out this form.
BAMF Health Clinical Trial Articles
BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
April 28, 2025
BAMF Health seeks breast cancer patients for groundbreaking imaging study
This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
April 24, 2025
Fueled by Hope and the Open Road
David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.
January 22, 2025